Georg Petzold, Pablo Gainza, Stefano Annunziato, Ilaria Lamberto, Peter Trenh, Laura A. McAllister, Bradley DeMarco, Laura Schwander, Richard D. Bunker, Mary Zlotosch, Rohitha SriRamaratnam, Samuel Gilberto, Gerasimos Langousis, Etienne J. Donckele, Chao Quan, Vaik Strande, Gian Marco De Donatis, Shanique B. Alabi, Jessica Alers, Michelle Matysik, Camille Staehly, Aurélie Dubois, Arnaud Osmont, Mackenzie Garskovas, David Lyon, Lars Wiedmer, Vladimiras Oleinikovas, Raphael Lieberherr, Nooreen T. Rubin, Daniel T. Lam, Xavier Lucas, Elisa Liardo, Nina Ilic Widlund, Andreas Ritzén, Ramon Miguel Caceres, Dominico Vigil, Jennifer Tsai, Owen Wallace, Marisa Peluso, Amine Sadok, Ralph Tiedt, Alison M. Paterson, Vladislav Zarayskiy, Bernhard Fasching, Debora Bonenfant, Markus Warmuth, John C. Castle, Sharon A. Townson
{"title":"Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition","authors":"Georg Petzold, Pablo Gainza, Stefano Annunziato, Ilaria Lamberto, Peter Trenh, Laura A. McAllister, Bradley DeMarco, Laura Schwander, Richard D. Bunker, Mary Zlotosch, Rohitha SriRamaratnam, Samuel Gilberto, Gerasimos Langousis, Etienne J. Donckele, Chao Quan, Vaik Strande, Gian Marco De Donatis, Shanique B. Alabi, Jessica Alers, Michelle Matysik, Camille Staehly, Aurélie Dubois, Arnaud Osmont, Mackenzie Garskovas, David Lyon, Lars Wiedmer, Vladimiras Oleinikovas, Raphael Lieberherr, Nooreen T. Rubin, Daniel T. Lam, Xavier Lucas, Elisa Liardo, Nina Ilic Widlund, Andreas Ritzén, Ramon Miguel Caceres, Dominico Vigil, Jennifer Tsai, Owen Wallace, Marisa Peluso, Amine Sadok, Ralph Tiedt, Alison M. Paterson, Vladislav Zarayskiy, Bernhard Fasching, Debora Bonenfant, Markus Warmuth, John C. Castle, Sharon A. Townson","doi":"10.1126/science.adt6736","DOIUrl":null,"url":null,"abstract":"<div >The CRL4<sup>CRBN</sup> E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4<sup>CRBN</sup> through next-generation molecular glue degraders.</div>","PeriodicalId":21678,"journal":{"name":"Science","volume":"389 6755","pages":""},"PeriodicalIF":45.8000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science","FirstCategoryId":"103","ListUrlMain":"https://www.science.org/doi/10.1126/science.adt6736","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The CRL4CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4CRBN through next-generation molecular glue degraders.
期刊介绍:
Science is a leading outlet for scientific news, commentary, and cutting-edge research. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million. Science’s authorship is global too, and its articles consistently rank among the world's most cited research.
Science serves as a forum for discussion of important issues related to the advancement of science by publishing material on which a consensus has been reached as well as including the presentation of minority or conflicting points of view. Accordingly, all articles published in Science—including editorials, news and comment, and book reviews—are signed and reflect the individual views of the authors and not official points of view adopted by AAAS or the institutions with which the authors are affiliated.
Science seeks to publish those papers that are most influential in their fields or across fields and that will significantly advance scientific understanding. Selected papers should present novel and broadly important data, syntheses, or concepts. They should merit recognition by the wider scientific community and general public provided by publication in Science, beyond that provided by specialty journals. Science welcomes submissions from all fields of science and from any source. The editors are committed to the prompt evaluation and publication of submitted papers while upholding high standards that support reproducibility of published research. Science is published weekly; selected papers are published online ahead of print.